The acquisition will enable Waystar to automate tasks such as utilisation management and clinical documentation integrity.

Waystar plans to acquire AI-driven revenue cycle management company Iodine Software, its first acquisition since going public ...

Waystar (WAY) said it will acquire health AI software company, Iodine Software, for a total enterprise value of $1.25B. The ...

Healthcare-software company Waystar has agreed to buy private-equity backed Iodine Software for $1.25 billion, including debt ...

Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced a definitive agreement to acquire ...

Healthcare software firm Waystar said on Wednesday it would buy privately held Iodine Software in a deal worth over $1.25 billion, including debt, to expand its use of artificial intelligence in ...

Waystar has signed a definitive agreement to acquire AI-powered revenue cycle management company Iodine Software. The proposed $1.25 billion deal will be funded with a 50/50 mix of cash and stock ...

Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

Louisville's newest public company raises nearly $1 billion © 2025 American City Business Journals. All rights reserved. Use ...

This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.

Waystar has agreed to acquire Iodine Software, an Austin-based provider of AI-powered clinical intelligence, for $1.25 billion. The sellers include majority shareholder Advent International and Iodine ...